Recent studies have suggested a bidirectional relationship between chronic periodontitis (CP) and diabetes mellitus (DM). Immunoregulatory factors such as cytokines play an important role in etiopathogenesis of both diseases. The aim of this study was to analyze variability in interleukin-1 (IL-1) gene cluster and IL-1β plasma levels in patients with CP, DM, and a combination of both diseases. A total of 1016 individuals participating in this case-control study-225 healthy controls, 264 patients with CP, 132 with type 1 diabetes (T1DM), and 395 patients with type 2 diabetes (T2DM)-were genotyped using methods based on polymerase chain reaction for IL-1 gene polymorphisms (IL-1A (-889C/T, rs1800587), IL-1B (+3953C/T, rs1143634), and IL-1RN (gene for IL-1 receptor antagonist, IL-1RA, 86 bp tandem repeats in intron 2)). Levels of IL-1β were measured by Luminex methods in subgroups of controls, CP, T1DM + CP, and T2DM + CP subjects. Although no significant associations were found in the genotype and allele frequencies of IL-1A (-889C/T), significant differences in the allele frequencies of IL-1B (+3953C/T) were observed between controls and CP patients (P < 0.05). In T1DM patients, IL-1RN ∗ S "short" allele and IL-1RN 12 genotype were significantly less frequent than those in controls (P < 0.01). In haplotype analysis, TTL haplotype decreased the risk of CP development (P < 0.01), whereas CCS and CTL haplotypes (P < 0.01 and P < 0.05) were associated with T1DM. Although IL-1β levels were measured significantly higher in mononuclear cells after stimulation by mitogens, HSP70, or selected periodontal bacteria than in unstimulated cells, IL-1 genotypes did not correlate with circulating IL-1β levels. In the Czech population, significant associations between the IL-1B polymorphism with CP and the IL-1RN variant with T1DM were found. Haplotype analysis suggests that variability in IL-1 gene cluster may be one of the factors in the CP and T1DM pathogenesis, although single variants of these polymorphisms are not substantial for protein production.

Clinic of Stomatology Institutions Shared with St Anne's Faculty Hospital Faculty of Medicine Masaryk University Brno 60200 Czech Republic

Department of Biochemistry Faculty of Medicine Masaryk University Brno 62500 Czech Republic

Department of Pathophysiology Faculty of Medicine Masaryk University Brno 62500 Czech Republic

Institute of Clinical and Experimental Dental Medicine General University Hospital and 1st Faculty of Medicine Charles University Prague 12000 Czech Republic

See more in PubMed

Socransky S. S., Haffajee A. D., Cugini M. A., Smith C., Kent R. L., Jr Microbial complexes in subgingival plaque. Journal of Clinical Periodontology. 1998;25(2):134–144. doi: 10.1111/j.1600-051x.1998.tb02419.x. PubMed DOI

Madianos P. N., Bobetsis Y. A., Kinane D. F. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. Journal of Clinical Periodontology. 2005;32(6):57–71. doi: 10.1111/j.1600-051x.2005.00821.x. PubMed DOI

Iacopino A. M. Periodontitis and diabetes interrelationships: role of inflammation. Annals of Periodontology. 2001;6(1):125–137. doi: 10.1902/annals.2001.6.1.125. PubMed DOI

Lalla E., Papapanou P. N. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nature Reviews Endocrinology. 2011;7(12):738–748. doi: 10.1038/nrendo.2011.106. PubMed DOI

Poitout V., Amyot J., Semache M., Zarrouki B., Hagman D., Fontés G. Glucolipotoxicity of the pancreatic beta cell. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2010;1801(3):289–298. doi: 10.1016/j.bbalip.2009.08.006. PubMed DOI PMC

Sonnenschein S. K., Meyle J. Local inflammatory reactions in patients with diabetes and periodontitis. Periodontol 2000. 2015;69(1):221–254. doi: 10.1111/prd.12089. PubMed DOI

Yan L. J. Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress. Journal of Diabetes Research. 2014;2014:11. doi: 10.1155/2014/137919.137919 PubMed DOI PMC

Odegaard J. I., Chawla A. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harbor Perspectives in Medicine. 2012;2(3) doi: 10.1101/cshperspect.a007724.a007724 PubMed DOI PMC

Chávarry N. G., Vettore M. V., Sansone C., Sheiham A. The relationship between diabetes mellitus and destructive periodontal disease: a meta-analysis. Oral Health and Preventive Dentistry. 2009;7(2):107–27. PubMed

Mealey B. L. Periodontal disease and diabetes: a two-way street. Journal of the American Dental Association. 2006;137:26–31. doi: 10.14219/jada.archive.2006.0404. PubMed DOI

Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;77:1627–52. PubMed

Steinkasserer A., Spurr N. K., Cox S., Jeggo P., Sim R. B. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1α and IL-1β loci. Genomics. 1992;13:654–657. doi: 10.1016/0888-7543(92)90137-h. PubMed DOI

Guzman S., Karima M., Wang H.-Y., Dyke T. E. V. Association between interleukin-1 genotype and periodontal disease in a diabetic population. Journal of Periodontology. 2003;74(8):1183–1190. doi: 10.1902/jop.2003.74.8.1183. PubMed DOI

Struch F., Dau M., Schwahn C., Biffar R., Kocher T., Meisel P. Interleukin-1 gene polymorphism, diabetes, and periodontitis: results from the Study of Health in Pomerania (SHIP) Journal of Periodontology. 2008;79(3):501–507. doi: 10.1902/jop.2008.070203. PubMed DOI

López N. J., Valenzuela C. Y., Jara L. Interleukin-1 gene cluster polymorphisms associated with periodontal disease in type 2 diabetes. Journal of Periodontology. 2009;80(10):1590–1598. doi: 10.1902/jop.2009.090134. PubMed DOI

Sharma N., Joseph R., Arun R., Chandni R., Srinivas K. L., Banerjee M. Cytokine gene polymorphism (interleukin-1β +3954, interleukin-6 [-597/-174] and tumor necrosis factor-α -308) in chronic periodontitis with and without type 2 diabetes mellitus. Indian Journal of Dental Research. 2014;25(3):375–380. PubMed

Deppe H., Mücke T., Wagenpfeil S., et al. Are selected IL-1 polymorphisms and selected subgingival microorganisms significantly associated to periodontitis in type 2 diabetes patients? a clinical study. BMC Oral Health. 2015;15(1):p. 143. doi: 10.1186/s12903-015-0132-5. PubMed DOI PMC

Pácal L., Varvařovská J., Rušavý Z., et al. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus. Archives of Physiology and Biochemistry. 2011;117(4):222–230. doi: 10.3109/13813455.2010.551135. PubMed DOI

Borilova Linhartova P., Vokurka J., Poskerova H., Fassmann A., Izakovicova Holla L. Haplotype analysis of interleukin-8 gene polymorphisms in chronic and aggressive periodontitis. Mediators of Inflammation. 2013;2013:p. 342351. doi: 10.1155/2013/342351. PubMed DOI PMC

Borilova Linhartova P., Kastovsky J., Lucanova S., et al. Interleukin-17A gene variability in patients with type 1 diabetes mellitus and chronic periodontitis: its correlation with IL-17 levels and the occurrence of periodontopathic bacteria. Mediators of Inflammation. 2016;2016:9. doi: 10.1155/2016/2979846.2979846 PubMed DOI PMC

Mcdowell T. L., Symons J. A., Ploski R., FØRre Ø., Duff G. W. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis and Rheumatism. 1995;38(2):221–228. doi: 10.1002/art.1780380210. PubMed DOI

Kornman K. S., Crane A., Wang H.-Y., et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. Journal of Clinical Periodontology. 1997;24(1):72–77. doi: 10.1111/j.1600-051x.1997.tb01187.x. PubMed DOI

Tarlow J. K., Blakemore A. I., Lennard A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Human Genetics. 1993;91(4):403–404. doi: 10.1007/bf00217368. PubMed DOI

Izakovicova Holla L., Borilova Linhartova P., Hrdlickova B., et al. Haplotypes of the IL-1 gene cluster are associated with gastroesophageal reflux disease and Barrett’s esophagus. Human Immunology. 2013;74(9):1161–1169. doi: 10.1016/j.humimm.2013.06.026. PubMed DOI

Bartova J., Borilova Linhartova P., Podzimek S., et al. The effect of IL-4 gene polymorphisms on cytokine production in patients with chronic periodontitis and in healthy controls. Mediators Inflamm. 2014;2014:11. doi: 10.1155/2014/185757.185757 PubMed DOI PMC

Tolusso B., Pietrapertosa D., Morelli A., et al. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics. 2006;7:683–695. doi: 10.2217/14622416.7.5.683. PubMed DOI

Preshaw P. M., Alba A. L., Herrera D., et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2011;55(1):21–31. doi: 10.1007/s00125-011-2342-y. PubMed DOI PMC

Bascones-Martínez A., González-Febles J., Sanz-Esporrín J. Diabetes and periodontal disease. Review of the literature. American Journal of Dentistry. 2014;27(2):63–67. PubMed

Brett P. M., Zygogianni P., Griffiths G. S., et al. Functional gene polymorphisms in aggressive and chronic periodontitis. Journal of Dental Research. 2016;84(12):1149–1153. doi: 10.1177/154405910508401211. PubMed DOI

Wagner J., Kaminski W. E., Aslanidis C., et al. Prevalence of OPG and IL-1 gene polymorphisms in chronic periodontitis. Journal of Clinical Periodontology. 2007;34(10):823–827. doi: 10.1111/j.1600-051x.2007.01132.x. PubMed DOI

Sakellari D., Koukoudetsos S., Arsenakis M., Konstantinidis A. Prevalence of IL-1A and IL-1B polymorphisms in a Greek population. Journal of Clinical Periodontology. 2003;30(1):35–41. doi: 10.1034/j.1600-051x.2003.300106.x. PubMed DOI

Bascones-Martínez A., Valderrama G., Vijande F., et al. Interleukin-1 gene polymorphisms and periodontal status in a Spanish population. Molecular Medicine Reports. 2012;5(5):1335–1339. doi: 10.3892/mmr.2012.792. PubMed DOI

Parkhill J. M., Hennig B. J. W., Chapple I. L. C., Heasman P. A., Taylor J. J. Association of interleukin-1 gene polymorphisms with early-onset periodontitis. Journal of Clinical Periodontology. 2000;27(9):682–689. doi: 10.1034/j.1600-051x.2000.027009682.x. PubMed DOI

Laine M. L., Farre M. A., Garcia-González M. A., et al. Polymorphisms of the interleukin-1 gene family, oral microbial pathogens, and smoking in adult periodontitis. Journal of Dental Research. 2016;80(8):1695–1699. doi: 10.1177/00220345010800080301. PubMed DOI

Sakellari D., Katsares V., Georgiadou M., Kouvatsi A., Arsenakis M., Konstantinidis A. No correlation of five gene polymorphisms with periodontal conditions in a Greek population. Journal of Clinical Periodontology. 2006;33(11):765–770. doi: 10.1111/j.1600-051x.2006.00983.x. PubMed DOI

Havemose-Poulsen A., Sørensen L. K., Bendtzen K., Holmstrup P. Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. Journal of Periodontology. 2007;78(3):475–492. doi: 10.1902/jop.2007.060135. PubMed DOI

Izakovičová Hollá L., Dvořáková N., Halaba T., Znojil V., Vácha J., Vaněk J. Analýza polymorfismů v genech pro interleukin-1 (IL-1) u českých pacientů s chronickou parodontitidou. Česká stomatologie. 2004;104(2):48–56.

da Silva F. R. P., Vasconcelos A. C. C. G., de Carvalho França L. F., Di Lenardo D., Nascimento H. M. S., Vasconcelos D. F. P. Association between the rs1143634 polymorphism in interleukin-1B and chronic periodontitis: results from a meta-analysis composed by 54 case/control studies. Gene. 2018;668:97–106. doi: 10.1016/j.gene.2018.05.067. PubMed DOI

da Silva F. R., Guimarães-Vasconcelos A. C., de-Carvalho-França L. F., et al. Relationship between -889 C/T polymorphism in interleukin-1A gene and risk of chronic periodontitis: evidence from a meta-analysis with new published findings. Medicina Oral Patología Oral y Cirugia Bucal. 2017;22(1):e7–e14. doi: 10.4317/medoral.21233. PubMed DOI PMC

Ding C., Zhao L., Sun Y., Li L., Xu Y. Interleukin-1 receptor antagonist polymorphism (rs2234663) and periodontitis susceptibility: a meta-analysis. Archives of Oral Biology. 2012;57(6):585–593. doi: 10.1016/j.archoralbio.2012.01.016. PubMed DOI

Morris R. W., Kaplan N. L. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genetic Epidemiology. 2002;23(3):221–233. doi: 10.1002/gepi.10200. PubMed DOI

Taba M., Jr, Souza S. L., Mariguela V. C. Periodontal disease: a genetic perspective. Brazilian Oral Research. 2012;26(1):32–38. doi: 10.1590/s1806-83242012000700006. PubMed DOI

Guo X., Wang Y., Wang C., Chen J. Identification of several hub-genes associated with periodontitis using integrated microarray analysis. Molecular Medicine Reports. 2014;11(4):2541–2547. doi: 10.3892/mmr.2014.3031. PubMed DOI PMC

Settin A., Ismail A., El-Magd M. A., El-Baz R., Kazamel A. Gene polymorphisms of TNF-α−308(G/A), IL-10−1082(G/A), IL-6−174(G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus. Autoimmunity. 2009;42(1):50–55. doi: 10.1080/08916930802292510. PubMed DOI

Ali R. A., Saber L. M., Al-Harbi A. M. A novel association between IL1-Ra (receptor antagonist) gene polymorphism and T1DM in Al-Madina Al-Mounawra. European Review for Medical and Pharmacological Sciences. 2015;19(19):3701–3708. PubMed

Santtila S., Savinainen K., Hurme M. Presence of the IL-1RA allele 2 (IL1RN  2) is associated with enhanced IL-1beta production in vitro. Scandinavian Journal of Immunology. 1998;47(3):195–198. doi: 10.1046/j.1365-3083.1998.00300.x. PubMed DOI

Danis V. A., Millington M., Hyland V. J., Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clinical and Experimental Immunology. 1995;99(2):303–310. doi: 10.1111/j.1365-2249.1995.tb05549.x. PubMed DOI PMC

Cullup H., Middleton P. G., Duggan G., Conn J. S., Dickinson A. M. Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals. Clinical and Experimental Immunology. 2004;137(2):351–358. doi: 10.1111/j.1365-2249.2004.02531.x. PubMed DOI PMC

Krikovszky D., Vásárhelyi B., Treszl A., et al. Genetic polymorphism of interleukin-1β is associated with risk of type 1 diabetes mellitus in children. European Journal of Pediatrics. 2002;161(9):507–508. doi: 10.1007/s00431-002-1030-9. PubMed DOI

Luotola K., Pietilä A., Zeller T, et al. Association between interleukin-1 (IL-1) gene variations of IL-1 receptor antagonist and the development type 2 diabetes. Journal of Internal Medicine. 2011;269(3):322–332. doi: 10.1111/j.1365-2796.2010.02294.x. PubMed DOI

Luotola K., Pääkkönen R., Alanne M., et al. Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis. J Clin Endocrinol Metab. 2009;94(11):4575–4583. doi: 10.1210/jc.2009-0666. PubMed DOI

Achyut B. R., Srivastava A., Bhattacharya S., Mittal B. Genetic association of interleukin-1β (−511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clinica Chimica Acta. 2007;377(1-2):163–169. doi: 10.1016/j.cca.2006.09.012. PubMed DOI

Banerjee M., Bid H., Konwar R., Agrawal CG. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian Journal of Medical Sciences. 2008;62(7):259–266. PubMed

Orozco A., Gemmell E., Bickel M., Seymour G. J. Interleukin-1 beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiology and Immunology. 2006;21(4):256–260. doi: 10.1111/j.1399-302x.2006.00292.x. PubMed DOI

Zhong Y., Slade G. D., Beck J. D., Offenbacher S. Gingival crevicular fluid interleukin-1?, prostaglandin E2and periodontal status in a community population. Journal of Clinical Periodontology. 2007;34(4):285–293. doi: 10.1111/j.1600-051x.2007.01057.x. PubMed DOI

Ertugrul A. S., Sahin H., Dikilitas A., Alpaslan N., Bozoglan A. Comparison of CCL28, interleukin-8, interleukin-1β and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis. Journal of Periodontal Research. 2012;48(1):44–51. doi: 10.1111/j.1600-0765.2012.01500.x. PubMed DOI

Becerik S., Öztürk V. Ö., Atmaca H., Atilla G., Emingil G. Gingival crevicular fluid and plasma acute-phase cytokine levels in different periodontal diseases. Journal of Periodontology. 2012;83(10):1304–1313. doi: 10.1902/jop.2012.110616. PubMed DOI

Salvi G. E., Beck J. D., Offenbacher S. PGE2, IL-1 β, and TNF-α responses in diabetics as modifiers of periodontal disease expression. Annals of Periodontology. 1998;3(1):40–50. doi: 10.1902/annals.1998.3.1.40. PubMed DOI

Aspriello S. D., Zizzi A., Tirabassi G., et al. Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. Journal of Periodontal Research. 2010;46(2):164–169. doi: 10.1111/j.1600-0765.2010.01324.x. PubMed DOI

Atieh M. A., Faggion C. M., Jr, Seymour G. J. Cytokines in patients with type 2 diabetes and chronic periodontitis: a systematic review and meta-analysis. Diabetes Research and Clinical Practice. 2014;104(2):e38–e45. doi: 10.1016/j.diabres.2014.02.002. PubMed DOI

Pérez F., Oyarzún A., Carrasco E., Angel B., Albala C., Santos J. L. Plasma levels of interleukin-1beta, interleukin-2 and interleukin-4 in recently diagnosed type 1 diabetic children and their association with beta-pancreatic autoantibodies. Revista Médica de Chile. 2004;132(4):413–420. PubMed

Alnek K., Kisand K., Heilman K., Peet A., Varik K., Uibo R. Increased blood levels of growth factors, proinflammatory cytokines, and Th17 cytokines in patients with newly diagnosed type 1 diabetes. PLoS One. 2015;10(12) doi: 10.1371/journal.pone.0142976.e0142976 PubMed DOI PMC

Liu F., Fu Y., Wei C., Chen Y., Ma S., Xu W. The expression of GPR109A, NF-kB and IL-1β in peripheral blood leukocytes from patients with type 2 diabetes. Annals of Clinical and Laboratory Science. 2014;44(4):443–448. PubMed

Satpathy A., Ravindra S., Thakur S., Kulkarni S., Porwal A., Panda S. Serum interleukin-1β in subjects with abdominal obesity and periodontitis. Obesity Research and Clinical Practice. 2015;9(5):513–521. doi: 10.1016/j.orcp.2015.01.005. PubMed DOI

Gümüş P., Nizam N., Nalbantsoy A., Özçaka Ö, Buduneli N. Saliva and serum levels of pentraxin-3 and interleukin-1β in generalized aggressive or chronic periodontitis. Journal of Periodontology. 2014;85(3):e40–46. doi: 10.1902/jop.2013.130281. PubMed DOI

Interleukin Gene Variability and Periodontal Bacteria in Patients with Generalized Aggressive Form of Periodontitis